Allergy Therapeutics (AGY): Corp Positive Phase II PQ data – significant value inflection | CyanConnode (CYAN): Corp FY 2018 revenue on track with new regions opened | Omega Diagnostics (ODX): Corp VISITEC CD4 update
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
21 May 2018 -
Author:
Mark Brewer -
Pages:
5
Allergy Therapeutics (AGY): Corp Positive Phase II PQ data – significant value inflection | CyanConnode (CYAN): Corp FY 2018 revenue on track with new regions opened | Omega Diagnostics (ODX): Corp VISITEC CD4 update